Logos Capital - A biotechnology focused fund dedicated to value creation and innovation
Description: LianBio is a biotechnology company focused on bringing paradigm-shifting medicines to patients through partnerships that provide access to the best science-driven therapeutic discoveries.
LianBio’s mission is to catalyze the development and accelerate availability of paradigm-shifting medicines to patients in China and major Asian markets through partnerships that provide access to the best science-driven therapeutic discoveries.
We are focused on building out a pipeline based on disease relevance to our target markets and the ability to impact patients with transformative mechanisms and precision-based therapeutics. We select programs with a strong scientific basis and clinical data and collaborate with world-class partners across a diverse array of therapeutic areas.
Logos Capital - A biotechnology focused fund dedicated to value creation and innovation